FundingWatcher
Home / Startups / Top health care startups / Health care startups in Schlieren, Switzerland

Health care startups in Schlieren, Switzerland

Updated 16 Nov 2026

Reset
Health care startups in Schlieren, Switzerland
One-time CSV
  • 22 funded companies, 14 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-health-care~schlieren-zurich.csv22 rows × 18 columns
CompanyCityLast roundAmountDate
Memo TherapeuticsSchlierenSeries C$22.0M2024-05-07
NovaGo TherapeuticsSchlierenSeries B$29.7M2026-08-31
HemotuneSchlierenSeries B$15.6M2024-03-25
CDR-Life AGSchlierenSeries A$76.0M2022-04-13
ImmunOs TherapeuticsSchlierenSeries C$11.0M2024-09-17
Anjarium BiosciencesSchlierenSeries A$60.4M2021-09-15
MalcisboSchlierenPre-seed$95K2010-07-07
Roche GlycartSchlierenSeries A$13.6M2003-11-26

8 rows of the CSV in 5 of its 18 columns.

22
Startups
$247.6M
Total raised
4
Funded in the last 12 months
$30.7M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

12 of 22
12 rows
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
NovaGo Therapeutics NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. Biotech Series B $29.7M 2026-08-31 $39.7M Kinled Holding, Pureos Bioventures 1 to 10 2015
ImmunOs Therapeutics ImmunOs Therapeutics is a clinical-stage biotechnology company. Biotech Series C $11.0M 2024-09-17 Lightspeed Venture Partners, Innosuisse, Mission BioCapital +1 11 to 50 2014
Memo Therapeutics Memo Therapeutics conducts biotechnology research in antibody discovery and immune repertoire analysis. Biotech Series C $22.0M 2024-05-07 $108.8M Verve Ventures, Kurma Partners, Pureos Bioventures +1 11 to 50 2012
Hemotune Hemotune develops a therapeutic blood purification platform for treating health conditions. Biotech Series B $15.6M 2024-03-25 Venture Kick, Innosuisse, Gebert Rüf Stiftung 11 to 50 2016
CDR-Life AG CDR-Life AG develops therapeutic antibody fragments for immuno-oncology. Biotech Series A $76.0M 2022-04-13 $76.0M RA Capital Management, Omega Funds, Jeito Capital 51 to 100 2017
Anjarium Biosciences Anjarium Biosciences develops non-viral gene therapies to treat genetic diseases. Biotech Series A $60.4M 2021-09-15 Gimv, Omega Funds, Pfizer Venture Investments +2 1 to 10 2017
Inthera Bioscience Inthera Bioscience develops inhibitors of intracellular protein interactions using a proprietary technology platform. Biotech Series A $5.5M 2018-06-26 Microsoft Accelerator, Novo Holdings, M Ventures +2 11 to 50 2013
Covagen Covagen develops protein-based therapeutics for inflammatory diseases and cancer. Biotech Series B $66.1M 2013-12-09 Ventech, Novartis Venture Fund, Andera Partners +2 11 to 50 2007
Pearltec AG Pearltec provides placement, positioning, and fixation solutions for patients in research imaging studies. Health care Series B $2.0M 2012-07-23 Tugboat 1 to 10 2008
Malcisbo Malcisbo develops novel carbohydrate-based vaccines for human and animal health. Biotech Pre-seed $95K 2010-07-07 $124K Venture Kick 1 to 10 2010
ESBATech ESBATech develops fully human antibody fragments for therapeutic applications using the single-chain antibody framework. Biotech Series B $22.0M 2008-08-07 Novartis Venture Fund, VI Partners, SV Health Investors +2 51 to 100 1998
Roche Glycart Roche Glycart researches, develops, and commercializes antibody-based biotechnology products. Biotech Series A $13.6M 2003-11-26 $13.6M Forbion Capital Partners, Novartis Venture Fund, BioMedPartners +1 101 to 250 2000

Table 1. Health care startups in Schlieren, Switzerland: the 12 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 22.

Largest rounds

Last 12 months
# Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
1 NovaGo Therapeutics NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. Biotech Series B $29.7M 2026-08-31 $39.7M Kinled Holding, Pureos Bioventures 1 to 10 2015

Table 2. Health care startups in Schlieren, Switzerland: the 1 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Venture Kick Startup incubator Schlieren, Switzerland 4 18%
2 Novartis Venture Fund Corporate venture arm Basel, Switzerland 3 14%
3 Pureos Bioventures Venture capital firm Küsnacht, Switzerland 2 9% 1 NovaGo Therapeutics
4 Innosuisse Government investment office Berne, Switzerland 2 9%
5 Omega Funds Secondary purchaser Boston, United States 2 9%
6 Gimv Private equity firm Antwerp, Belgium 2 9%
7 Ysios Capital Venture capital firm San Sebastian, Spain 1 5%
8 Kurma Partners Venture capital firm Paris, France 1 5%
9 Verve Ventures Venture capital firm Zug, Switzerland 1 5%
10 Kinled Holding Private equity firm New York, United States 1 5% 1 NovaGo Therapeutics
11 Gebert Rüf Stiftung Entrepreneurship program Basel, Switzerland 1 5%
12 RA Capital Management Startup incubator Boston, United States 1 5%
13 Jeito Capital Private equity firm Paris, France 1 5%
14 Mission BioCapital Venture capital firm Cambridge, United States 1 5%
15 Lightspeed Venture Partners Venture capital firm Menlo Park, United States 1 5%

Table 3. Health care startups in Schlieren, Switzerland: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 17 77% $247.4M
Software 3 14% $4K
Artificial intelligence 1 5% $4K

Table 4. Health care startups in Schlieren, Switzerland by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 4 18% $106K
Seed 4 18% $7.8M
Series A 6 27% $60.4M
Series B 5 23% $22.0M
Series C 2 9% $22.0M
Series D+ 1 5%

Table 5. Health care startups in Schlieren, Switzerland by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 1 25% $183K
August 2026 1 25% $29.7M
February 2026 1 25% $873K
January 2026 1 25%

Table 6. Health care startups in Schlieren, Switzerland: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 4 18% $30.7M
2025 1 5% $7.8M
2024 3 14% $48.6M
2022 2 9% $76.0M
2021 1 5% $60.4M
2019 1 5%

Table 7. Health care startups in Schlieren, Switzerland by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 3 14%
2020 to 2022 1 5%
2015 to 2019 6 27%
2010 to 2014 7 32%
Before 2010 5 23%

Table 8. Health care startups in Schlieren, Switzerland by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 13 59%
11 to 50 5 23%
51 to 100 3 14%
101 to 250 1 5%

Table 9. Health care startups in Schlieren, Switzerland by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many health care startups in Schlieren, Switzerland are on the list?
22, in the file dated 16 November 2026. 4 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 22 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Health care startups in Schlieren, Switzerland: 22 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Other sectors in Schlieren

Health care startups elsewhere

Cite: FundingWatcher, 22 funded health care companies in Schlieren, Switzerland, 16 November 2026. https://fundingwatcher.com/startups/health-care/schlieren-zurich/